Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (NQ:EDAP)

1.400 UNCHANGED
Streaming Delayed Price Updated: 3:54 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

< Previous 1 2 3 4 5 Next >
EDAP Announces Third Quarter 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at the Jefferies London Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference
From EDAP TMS S.A.
Via GlobeNewswire
Edap TMS's Earnings Outlook
 
Via Benzinga
Recap: Edap TMS Q1 Earnings
 
Via Benzinga
EDAP Announces Second Quarter 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at the Jefferies Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Edap TMS Earnings Preview
 
Via Benzinga
Edap TMS's Earnings: A Preview
 
Via Benzinga
EDAP Announces First Quarter 2023 Financial Results
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience
From EDAP TMS S.A.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
From EDAP TMS S.A.
Via GlobeNewswire
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
EDAP Announces Record Q4 US Focal One Placements
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
From EDAP TMS S.A.
Via GlobeNewswire
EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis
From EDAP TMS S.A.
Via GlobeNewswire
EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
From EDAP TMS S.A.
Via GlobeNewswire
Intuit To $490? Here Are 5 Other Price Target Changes For Friday
Barclays cut Intuit Inc. (NASDAQ: INTU) price target from $502 to $490. . Barclays analyst Raimo Lenschow maintained an Overweight rating on the stock. Intuit shares fell 3% to close at $381.88 on... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS